It Is Time to Define Huntington's Disease Onset more Clearly.
作者信息
Franklin Gustavo L, Ferreira Carlos Henrique, Teive Hélio A G
机构信息
Movement Disorders Unit, Neurology Service, Internal Medicine Department Hospital de Clínicas, Federal University of Paraná Curitiba Brazil.
Neurological Diseases Group, Graduate Program in Internal Medicine, Internal Medicine Department Hospital de Clínicas, Federal University of Paraná Curitiba Brazil.
出版信息
Mov Disord Clin Pract. 2021 Mar 8;8(3):493-494. doi: 10.1002/mdc3.13174. eCollection 2021 Apr.
Abstract
摘要
相似文献
1
It Is Time to Define Huntington's Disease Onset more Clearly.
Mov Disord Clin Pract. 2021 Mar 8;8(3):493-494. doi: 10.1002/mdc3.13174. eCollection 2021 Apr.
2
Disease Onset in Huntington's Disease: When Is the Conversion?
Mov Disord Clin Pract. 2021 Jan 31;8(3):352-360. doi: 10.1002/mdc3.13148. eCollection 2021 Apr.
3
Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Lancet Neurol. 2018 Nov;17(11):986-993. doi: 10.1016/S1474-4422(18)30294-1. Epub 2018 Sep 19.
4
Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Lancet Neurol. 2014 Dec;13(12):1193-201. doi: 10.1016/S1474-4422(14)70238-8. Epub 2014 Nov 3.
5
Longitudinal assessment of the Unified Huntington's Disease Rating Scale (UHDRS) and UHDRS-For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington's disease.
Eur J Neurol. 2019 May;26(5):780-785. doi: 10.1111/ene.13889. Epub 2019 Jan 27.
6
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20.
7
Assessment Scales for Patients with Advanced Huntington's Disease: Comparison of the UHDRS and UHDRS-FAP.
Mov Disord Clin Pract. 2018 Aug 24;5(5):527-533. doi: 10.1002/mdc3.12646. eCollection 2018 Sep-Oct.
8
Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures.
Mov Disord. 2011 Oct;26(12):2267-73. doi: 10.1002/mds.23816. Epub 2011 Jun 9.
9
Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease.
Eur J Neurol. 2015 Oct;22(10):1378-84. doi: 10.1111/ene.12750. Epub 2015 Jun 13.
10
Huntington's Disease: Characteristics of Fallers.
Physiother Res Int. 2014 Feb 10. doi: 10.1002/pri.1577.
引用本文的文献
1
"I don't have Huntington's disease": the boundaries between acceptance and understanding.
Arq Neuropsiquiatr. 2023 Jul;81(7):696-699. doi: 10.1055/s-0043-1768158. Epub 2023 Jul 26.
本文引用的文献
1
Disease Onset in Huntington's Disease: When Is the Conversion?
Mov Disord Clin Pract. 2021 Jan 31;8(3):352-360. doi: 10.1002/mdc3.13148. eCollection 2021 Apr.
2
Is Ataxia an Underestimated Symptom of Huntington's Disease?
Front Neurol. 2020 Nov 12;11:571843. doi: 10.3389/fneur.2020.571843. eCollection 2020.
3
Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories.
Mov Disord Clin Pract. 2019 Aug 23;6(7):541-546. doi: 10.1002/mdc3.12808. eCollection 2019 Sep.
4
Motor onset and diagnosis in Huntington disease using the diagnostic confidence level.
J Neurol. 2015 Dec;262(12):2691-8. doi: 10.1007/s00415-015-7900-7. Epub 2015 Sep 26.
5
Refining the diagnosis of Huntington disease: the PREDICT-HD study.
Front Aging Neurosci. 2013 Apr 2;5:12. doi: 10.3389/fnagi.2013.00012. eCollection 2013.
Zotero 插件